Scientific Integrity And Ethics

Henrietta Lacks: Stolen Cells, Born Today Henrietta Lacks, born on this day in 1920, unknowingly became an immortal figure in modern medicine. Her story, though initially shrouded in secrecy, is now a cornerstone in discussions about bioethics and medical advancements. Lacks’ cells, taken without her consent in 1951, have revolutionized scientific research and continue to impact healthcare today. The story of [Henrietta Lacks] is one of both incredible scientific breakthrough and profound ethical questions. Diagnosed with cervical cancer, Lacks underwent treatment at Johns Hopkins Hospital, where, unbeknownst to her, cells were harvested from her tumor. These cells, unlike others at the time, thrived and multiplied in a lab setting, becoming known as the HeLa cell line. This breakthrough allowed scientists to conduct experiments and research in ways previously impossible, leading to pivotal discoveries. The HeLa cells played an instrumental role in developing the polio vaccine, as well as advancements in cloning, gene mapping, and in vitro fertilization. Their use accelerated scientific progress at an unprecedented rate, contributing significantly to our understanding of diseases and treatments. However, the lack of informed consent and the subsequent commercialization of her cells raised serious ethical concerns. The Lacks family remained unaware of the cell line’s existence for decades, highlighting the systemic issues of racial and economic disparities within the medical system. The legacy of Henrietta Lacks serves as a constant reminder of the importance of ethical considerations in scientific research. It prompts ongoing conversations about patient rights, informed consent, and the need for equitable practices within the medical field. Her story forces us to confront the complexities of scientific advancement and the potential impact on marginalized communities. Even though she passed away too soon, her contribution to science is everlasting.

🔬 Towards Decentralized and Privacy-Preserving Clinical Trials 🧠💡Register, learn and build Decentralization in clinical research is not just about scalability or cost-efficiency. It’s a cryptographic transformation that redefines trust and data sovereignty in medical innovation. Technologies like Zero-Knowledge Proofs (ZKPs) and Fully Homomorphic Encryption (FHE) are enabling a new paradigm in decentralized trials: ✅ Privacy without compromising verification: With ZKPs, patients can prove eligibility (inclusion/exclusion criteria) without revealing their full medical history. Compliance is validated without exposing sensitive data. ✅ Computation over encrypted data (FHE): FHE allows researchers to run statistical analyses and predictive models directly on encrypted datasets. No need to decrypt—privacy is preserved even during processing. Ideal for multicenter trials or pharmacogenomic studies. ✅ Traceability without surveillance: Combining blockchain with ZK/FHE enables immutable and auditable recording of clinical events (dosage, adverse effects, outcomes) without identifying the patient. 🌐 In this new model: Data stays where it’s generated (edge computing, patient devices) No centralized data hoarding or exposure risks GDPR and similar regulations are met by design, not workaround 📣 If you're working at the intersection of digital health, cryptography and clinical innovation, this is the future: crypto-technology powering secure, precise, and ethical research. #ZKProofs #FHE #DeSci #DecentralizedTrials #PrivacyByDesign #Web3Health #DigitalTrust #Blockchain #ClinicalResearch #HealthTech Anthony Joaquim José Daniel Dr. Hidenori Vivek Helena Lars Yousuke Carlos Iker Paris João Domingos

Some academic supervisors seem to believe that refusing co-authorship with their doctoral students is an ethical stance—a way to "protect the student's CV" or ensure students get "sole credit." I want to challenge this assumption. The "heroic individual author" is part of a modernist, progressivist model of knowledge production that doesn't reflect how research actually works. Knowledge is collaborative, dialogic, and socially situated. When we pretend otherwise, we perpetuate myths about academic work that harm transparent research practices. COPE guidelines explicitly address "ghost authorship"—when someone makes substantial contributions to research but isn't named as an author. This isn't just about gift authorship (the problem we talk about more often). Ghost authorship is equally problematic. When supervisors contribute substantively to research design, analysis, or writing, refusing authorship doesn't protect students—it obscures the actual intellectual labour behind the work. In qualitative research in particular, this matters. Our epistemological and analytical positions shape interpretation. When supervisors' contributions to conceptual framing, analytical decisions, or theoretical positioning are obscured, the work risks being unreflexive about the dialogic process through which meaning was constructed. Transparency about collaboration is part of methodological rigour. Refusing co-authorship when we've made genuine contributions isn't an ethical position—it potentially misrepresents the research process. And it may actually disadvantage early career researchers. Papers with established academics as co-authors gain significantly higher visibility, citation rates, and readership. Our doctoral students benefit from: • Increased paper visibility through supervisor networks and reputation • Higher citation rates that boost early career metrics during crucial job market years • Transparent acknowledgment of collaborative intellectual work • Modeling of ethical authorship practices they'll use throughout their careers • Recognition that knowledge production is inherently collaborative Of course, students should absolutely have sole-authored publications where appropriate. But framing automatic refusal of co-authorship as the ethical choice fundamentally misunderstands both research ethics and how collaborative knowledge production works. Supervisors are collaborators, not just gatekeepers. We should be honest about the work we do together. What are your experiences with supervisor co-authorship? I'd be interested to hear different perspectives. #AcademicTwitter #PhDSupervision #ResearchEthics #HigherEducation #AcademicPublishing

𝗘𝘁𝗵𝗶𝗰𝗮𝗹 𝗖𝗼𝗻𝘀𝗶𝗱𝗲𝗿𝗮𝘁𝗶𝗼𝗻𝘀 𝗶𝗻 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 ✅ 𝗪𝗵𝘆 𝗔𝗿𝗲 𝗘𝘁𝗵𝗶𝗰𝗮𝗹 𝗖𝗼𝗻𝘀𝗶𝗱𝗲𝗿𝗮𝘁𝗶𝗼𝗻𝘀 𝗜𝗺𝗽𝗼𝗿𝘁𝗮𝗻𝘁?  • Protect participants from harm  • Maintain integrity of the research process  • Build trust with the public and academic community  • Ensure compliance with institutional and legal standards 🔑 𝗞𝗲𝘆 𝗘𝘁𝗵𝗶𝗰𝗮𝗹 𝗣𝗿𝗶𝗻𝗰𝗶𝗽𝗹𝗲𝘀 Here are the core principles you must address in your research: 𝟭. 𝗜𝗻𝗳𝗼𝗿𝗺𝗲𝗱 𝗖𝗼𝗻𝘀𝗲𝗻𝘁 𝗣𝗮𝗿𝘁𝗶𝗰𝗶𝗽𝗮𝗻𝘁𝘀 𝗺𝘂𝘀𝘁:  • Be fully informed about the purpose, procedures, risks, and benefits of the research  • Understand their participation is voluntary  • Have the opportunity to withdraw at any time without consequences ✅̲ ̲𝙴̲𝚡̲𝚊̲𝚖̲𝚙̲𝚕̲𝚎̲:̲ “All participants were provided with an informed consent form outlining the study’s objectives, procedures, and their rights, including the right to withdraw at any point.” 𝟮. 𝗖𝗼𝗻𝗳𝗶𝗱𝗲𝗻𝘁𝗶𝗮𝗹𝗶𝘁𝘆 𝗮𝗻𝗱 𝗔𝗻𝗼𝗻𝘆𝗺𝗶𝘁𝘆  • Ensure participant data is kept confidential  • Remove identifying details where possible (anonymization)  • Secure data storage (e.g., encrypted files, password-protected systems) ✅̲ ̲𝙴̲𝚡̲𝚊̲𝚖̲𝚙̲𝚕̲𝚎̲:̲ “Participants’ names and identifying information were excluded from all reports, and data were stored securely in encrypted files.” 𝟯. 𝗔𝘃𝗼𝗶𝗱𝗮𝗻𝗰𝗲 𝗼𝗳 𝗛𝗮𝗿𝗺  • Protect participants from physical, psychological, emotional, or social harm  • Screen for potential risks before the study begins ̲✅̲ ̲𝙴̲𝚡̲𝚊̲𝚖̲𝚙̲𝚕̲𝚎̲:̲ “The study design minimized psychological discomfort by avoiding sensitive or triggering questions. Support resources were provided if distress occurred.” 𝟰. 𝗩𝗼𝗹𝘂𝗻𝘁𝗮𝗿𝘆 𝗣𝗮𝗿𝘁𝗶𝗰𝗶𝗽𝗮𝘁𝗶𝗼𝗻  • Participation should be completely voluntary  • No coercion, pressure, or manipulation  • Particularly important in vulnerable populations (e.g., children, prisoners) ✅̲ ̲𝙴̲𝚡̲𝚊̲𝚖̲𝚙̲𝚕̲𝚎̲:̲ “Participation was entirely voluntary, and no incentives were used that might pressure individuals to take part.” 𝟱. 𝗘𝘁𝗵𝗶𝗰𝗮𝗹 𝗔𝗽𝗽𝗿𝗼𝘃𝗮𝗹  • Obtain approval from a recognized Ethics Review Board (ERB) or Institutional Review Board (IRB)  • Submit a detailed study protocol for review before data collection ̲✅̲ ̲𝙴̲𝚡̲𝚊̲𝚖̲𝚙̲𝚕̲𝚎̲:̲ “This research received ethical approval from the University Research Ethics Committee (Ref: 2025/101).” 𝟲. 𝗥𝗲𝘀𝗽𝗲𝗰𝘁 𝗳𝗼𝗿 𝗩𝘂𝗹𝗻𝗲𝗿𝗮𝗯𝗹𝗲 𝗣𝗼𝗽𝘂𝗹𝗮𝘁𝗶𝗼𝗻s If researching children, the elderly, refugees, etc., additional safeguards must be in place:  • Consent from guardians  • Simplified language  • Ongoing monitoring of participant well-being 7. Honesty and Integrity  • Report findings truthfully  • Do not falsify or manipulate data  • Acknowledge sources and avoid plagiarism ✅̲ ̲𝙴̲𝚡̲𝚊̲𝚖̲𝚙̲𝚕̲𝚎̲:̲ “All data were reported honestly, and no fabrication or manipulation was involved in the analysis.”

Ethical violence in research. When researchers come into Indigenous communities, extract data and stories, publish findings, and leave without sharing results or compensation, that is ethical violence. It's called "research." But it's extraction. It's colonization dressed in academic language. Ethical research requires: ✦ Community consent, not just individual consent ✦ Shared ownership of findings ✦ Compensation for knowledge shared ✦ Community benefit, not just researcher benefit ✦ Accountability to the community, not just ethics boards ✦ Respecting Indigenous data sovereignty If you research with Indigenous communities: your job is not to be seen as ethical. Your job is to be accountable to the community you serve. This is the work of decolonizing research. 💜 #IndigenousDataSovereignty #DecolonizingResearch #CommunityAccountability #IndigenousWisdom #ResearchJustice

As the use of #AI_Agents in research continues to expand, David Resnik & I discuss the #ethics of using these tools in two new papers: A shorter, more accessible article focused on human-controlled agents (co-authored with Maya Murad) is published in The Hastings Center for Bioethics (https://lnkd.in/g4Btfn_Y). A more comprehensive piece addressing semi- and fully autonomous agents (co-authored with Rico Hauswald) is published in AI & Ethics (https://lnkd.in/gBQebzVr). We discuss several ethical concerns: conducting immoral research that may harm humans and other forms of life; increases in biased, erroneous, or deceptive outputs; confidentiality and data protection risks; overreliance on automated systems; diffusion of responsibility and accountability; deskilling of researchers; job losses; AI-generated research beyond human comprehension; and erosion of trust in the research enterprise.

The creation of a chimeric macaque marks a staggering turning point in the field of biotechnology, blurring the lines between disparate genetic identities within a single living being. By successfully integrating donor pluripotent stem cells into a host embryo, researchers have produced a primate that literally glows with the evidence of its dual heritage. The neon green hue of its eyes and the yellow tint of its fingertips serve as luminous proof of high-level chimerism, where donor cells permeated nearly every vital system from the heart to the brain. This achievement far surpasses previous attempts where donor contribution was negligible, proving that a complex organism can be engineered as a mosaic of distinct genetic lines. While the life of this particular primate was brief, its impact on the future of medicine is immense. The primary goal of such high-level cell integration is to create more sophisticated models for studying human diseases that current laboratory methods cannot fully replicate. Specifically, researchers aim to target complex neurological conditions such as Parkinson’s disease and Amyotrophic Lateral Sclerosis. By utilizing gene-editing tools on these chimeric blueprints, scientists can observe the progression of these degenerative disorders and test potential therapies within a biological environment that closely mirrors our own. This bridge between basic stem cell research and clinical application offers a new horizon for treating conditions that have long remained elusive. However, the birth of such a creature inevitably invites a profound ethical dialogue regarding the boundaries of genetic manipulation. The physical markers of the experiment—those glowing eyes and vibrant limbs—act as a stark reminder of the power humans now wield over the natural order. Critics argue that creating sentient beings with such high levels of donor integration raises questions about the moral status and welfare of these "living blueprints." There is an inherent tension between the pursuit of medical necessity and the sanctity of biological identity, as well as the potential for unforeseen suffering in creatures with altered genetic structures. Ultimately, this milestone represents both a technical triumph and a moral crossroads for the scientific community. As researchers refine the process to ensure longer survival and more precise cell distribution, the potential to save human lives through highly accurate disease modeling grows more tangible. Yet, the journey toward these medical breakthroughs requires a cautious navigation of the ethical landscape to ensure that progress does not outpace our collective conscience. This achievement is a provocative step into a future where the blueprints of life are increasingly fluid and the definition of a single organism is redefined through the lens of modern biotechnology. #Biotechnology #StemCellResearch #MedicalScience #GeneticEngineering #ScientificBreakthrough #EthicalScience #FutureOfMedic

Serious Breach in Clinical Trials: Failure to Maintain Participant Confidentiality 🚨 Breaching participant confidentiality in a clinical trial can lead to legal, ethical, and regulatory consequences. Could this happen in your clinical trial? Example : During a clinical trial, personal health information (PHI) of several participants was inadvertently shared with unauthorized personnel due to improper handling of clinical trial documents. Additionally, electronic case report forms (eCRFs) were stored without sufficient encryption, making them vulnerable to unauthorized access. Some participants were contacted by third parties without prior consent, violating data protection regulations. Why Is This a Serious Breach? This is classified as a serious breach because: ❗Participant privacy is compromised, violating ethical and legal obligations. ❗Regulatory non-compliance, particularly with GDPR, HIPAA, or other data protection laws. ❗Loss of participant trust, potentially affecting clinical trial recruitment and retention. Corrective Actions If a confidentiality breach occurs, immediate corrective actions should include: 🔹Reporting the incident to regulatory authorities and ethics committees. 🔹Conducting a root cause analysis to identify how the breach occurred. 🔹Implementing corrective security measures to prevent further unauthorized access. 🔹Providing retraining for clinical trial personnel on confidentiality policies. Preventive Actions To prevent confidentiality breaches in the future: 🔹Use secure electronic data capture (EDC) systems with strong encryption. 🔹Implement access control measures, ensuring only authorized personnel can view sensitive data. 🔹Conduct regular security audits to identify potential vulnerabilities. 🔹Ensure participant data is de-identified whenever possible. How Could Sponsors Have Prevented This Serious Breach? Sponsors can ensure participant confidentiality by: ✅ Requiring data security protocols in site agreements. ✅ Conducting regular compliance checks at trial sites. ✅ Providing continuous training on data privacy regulations. ✅ Enforcing strict data access policies to limit exposure risks. Consequences for the Clinical Trial Failure to protect participant confidentiality can result in: ⚠️ Regulatory penalties, including fines and restrictions on trial operations. ⚠️ Legal liabilities, exposing sponsors and investigators to lawsuits. ⚠️ Reputational damage, affecting credibility and future collaborations. ⚠️ Participant withdrawal, leading to delays or trial failure. 📢 Key Takeaway: Protecting participant confidentiality is fundamental to ethical and regulatory compliance. What safeguards does your clinical trial have in place to ensure data privacy? Let’s discuss in the comments!

As a scholar and scientist from the Global South who leads the Earth Daughters's Indigenous science research, I offer these critical reflections: Researchers are accountable for all harm their work causes, especially to Indigenous and Global South communities. Any harm caused by research is inseparable from its author, particularly in the Global South where vulnerabilities are heightened. Accountability persists long after publication, especially when the research impacts marginalized populations. Indirect damage still originates from the researcher’s actions, and this is critical when working with historically exploited communities. Ethical responsibility demands foresight of all possible harm, especially in contexts of cultural sensitivity and power imbalance. A researcher cannot escape the moral weight of their findings, particularly when those findings affect Indigenous knowledge systems. Every discovery binds its creator to its outcomes, especially when those outcomes shape lives in the Global South. Ignoring harm amplifies culpability, not absolves it—most of all when harm falls on vulnerable communities. Research and researcher are permanently linked in ethical judgment, especially when trust and equity are at stake in local or Indigenous contexts.